All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Semax and Selank on TikTok: hype vs. the actual evidence

PyreLifts

TikTok creator

2.0K viewsWatch on TikTok→

Quick answer

Semax is a synthetic ACTH-derived peptide with preclinical evidence for BDNF upregulation and neuroprotective effects, registered as a nasal drug in Russia for cognitive and cerebrovascular indications but not approved by the FDA. Selank is a tuftsin analog with reported anxiolytic and nootropic properties linked to GABAergic and serotonergic modulation, also registered in Russia but lacking large-scale, independently replicated human trials. Neither compound has established dosing protocols, long-term safety data, or regulatory approval for use in the United States.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.

What did @pyrelifts actually say?

The creator's core argument is that people misunderstand semax and selank because they expect them to feel like stimulants. They say semax "is specifically meant to upregulate BDNF and help in neuroplasticity" while selank "helps regulate your neurotransmitters working through your GABA receptors" for anti-anxiety effects. The overall message: these are tools for brain function over time, not quick-hit performance boosters. They also note both compounds are used in Russia for cognitive disorders.

That framing is actually more responsible than most peptide content on TikTok. The creator isn't promising superhuman focus or overnight transformation. They're trying to reset expectations downward, which, for a peptide audience, is a rare move worth acknowledging before we get into the details.

Does the science back this up?

Partially, yes. The BDNF claim for semax has real preclinical support, but the human evidence is thin. The GABA mechanism for selank is plausible but oversimplified.

Semax is a synthetic heptapeptide derived from ACTH(4-7). Russian research, particularly from Dolotov et al. (2006, Journal of Molecular Neuroscience), showed semax increased BDNF and NGF expression in rat brain tissue. There is also early human trial data from Russian institutions suggesting cognitive benefits in stroke recovery patients. However, none of this constitutes rigorous, replicated, peer-reviewed evidence by Western regulatory standards. The BDNF upregulation narrative is not wrong, but calling it settled science would be a stretch.

Selank is a synthetic analog of tuftsin with reported anxiolytic properties. Semenova et al. (2010, Bulletin of Experimental Biology and Medicine) found selank modulated GABA-A receptor activity in animal models, supporting the creator's claim. But saying it works "through your GABA receptors" as a clean mechanism oversimplifies what is likely a more diffuse neurochemical effect involving serotonin and enkephalin pathways as well.

What did they get wrong (or right)?

They got the stimulant distinction right. They got the BDNF framing mostly right. Where they stumble is the GABA explanation for selank, and the vague claim about Russian clinical use.

Calling selank a GABA-receptor compound without qualification is misleading. Unlike benzodiazepines, which are direct GABA-A positive allosteric modulators, selank's interaction with GABAergic signaling appears indirect and context-dependent. Framing it as working "through your GABA receptors" could lead listeners to assume it functions like an anxiolytic drug, which is not supported by available evidence.

The Russia clinical use point is accurate in a narrow sense. Semax holds registration as a nasal spray drug in Russia for conditions including stroke and cognitive impairment. Selank is similarly registered. But "used in Russia" is doing a lot of heavy lifting here. Russian drug approval standards differ significantly from FDA or EMA processes, and citing it as validation without that context can mislead audiences into thinking these compounds have a stronger evidentiary base than they do.

On the positive side: "they're not anything crazy" is an honest, grounded statement that many creators in this space would never say. Credit where it's due.

What should you actually know?

If you're considering semax or selank, the honest answer is that the human evidence base is small and mostly from Russian sources that are difficult to independently verify. That doesn't mean the compounds are useless, but it does mean you're operating with significant uncertainty.

Both compounds are not FDA-approved. In the United States, they are not legally available as prescription medications and are not approved for compounding under standard pharmacy regulations. Any product sold domestically exists in a regulatory gray area, and quality control varies widely between suppliers.

The creator's reframing of these as long-term neurological support tools rather than acute stimulants is reasonable, but it should come with a caveat: the "training yourself to get smarter" framing implies a durability of effect that has not been demonstrated in robust human trials. The neuroplasticity narrative is compelling and biologically plausible, but plausible is not the same as proven. Talk to a licensed clinician before using either compound.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

Peptide social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 5 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For Semax and Selank on TikTok: hype vs. the actual evidence, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

Semax and Selank on TikTok: hype vs. the actual evidence is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

Compare providers, services and access requirements in the directory before contacting a suitable care team.

Claim verdict

The useful answer behind this video

Claim being checked

Semax is a synthetic ACTH-derived peptide with preclinical evidence for BDNF upregulation and neuroprotective effects, registered as a nasal drug in Russia for cognitive and cerebrovascular indications but not approved by the FDA.

FormBlends verdict

Semax is a synthetic ACTH-derived peptide with preclinical evidence for BDNF upregulation and neuroprotective effects, registered as a nasal drug in Russia for cognitive and cerebrovascular indications but not approved by the FDA. Selank is a tuftsin analog with reported anxiolytic and nootropic properties linked to GABAergic and serotonergic modulation, also registered in Russia but lacking large-scale, independently replicated human trials. Neither compound has established dosing protocols, long-term safety data, or regulatory approval for use in the United States.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • Semax is a synthetic ACTH-derived peptide with preclinical evidence for BDNF upregulation and neuroprotective effects, registered as a nasal drug in Russia for cognitive and cerebrovascular indications but not approved by the FDA. Selank is a tuftsin analog with reported anxiolytic and nootropic properties linked to GABAergic and serotonergic modulation, also registered in Russia but lacking large-scale, independently replicated human trials. Neither compound has established dosing protocols, long-term safety data, or regulatory approval for use in the United States.
  • Semax's BDNF-upregulating effects have preclinical support (Dolotov et al., 2006) but no large-scale human RCTs confirm this translates to measurable cognitive improvement in healthy adults.
  • Selank's anxiolytic effects involve GABAergic signaling but also serotonin and enkephalin pathways, making the 'GABA receptor' explanation an oversimplification of a more complex mechanism.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • Semax's BDNF-upregulating effects have preclinical support (Dolotov et al., 2006) but no large-scale human RCTs confirm this translates to measurable cognitive improvement in healthy adults.
  • Selank's anxiolytic effects involve GABAergic signaling but also serotonin and enkephalin pathways, making the 'GABA receptor' explanation an oversimplification of a more complex mechanism.
  • Both compounds are registered drugs in Russia, but Russian drug approval standards differ substantially from FDA or EMA requirements and should not be treated as equivalent validation.
  • Neither semax nor selank is FDA-approved, and both exist in a legal and regulatory gray zone in the United States with no standardized quality control for available products.
  • The 'training yourself to get smarter' framing is biologically plausible based on BDNF's role in synaptic plasticity, but no human trial has demonstrated durable IQ-level or performance gains from either peptide.
  • Selank's calming effect is real enough in animal models to be considered pharmacologically active, but comparing it to a stimulant-like compound in any direction risks misleading users about its actual subjective profile.
  • Anyone considering these compounds should consult a licensed clinician. The absence of FDA approval means there is no established safe dosing range verified through regulated clinical trials.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

PyreLifts · TikTok creator

2.0K views on this video

As always, full breakdown on the Skool community!#fyp #foryou #semax #selank #guide

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by PyreLifts, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.